Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 452 participants.

Also called NCT04657133

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 452 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04657133
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04657133. Randomized; quadruple masking; primary purpose treatment. Start 2021-04-22 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage
Acronym
RICH-2
Condition
Intracerebral Hemorrhage
Condition
Acute Stroke
Intervention (Device)
Remote ischemic conditioning
Intervention (Device)
Sham remote ischemic conditioning
Intervention (Drug)
Standard medication therapy
Lead sponsor
Capital Medical University (class: other)

Record details

Record id
cardio:ct-nct04657133
Content hash
b0786f4d52a1a28c4d36e54db9aab17bbf3e09707e895fd07e7558ab95f531a9